Ingredion Conference Call Summary Company Overview - **Company**: Ingredion - **Industry**: Global ingredient solutions provider, primarily serving the food and beverage industry, with nearly 70% of revenues from this sector. Also serves paper making, corrugated box industries, and specialty ingredients for pharma and personal care markets [4][5] Key Financial Highlights - **Record Results**: In 2025, Ingredion reported $950 million in cash from operations, returning approximately half to shareholders [1] - **Gross Profit Margin**: Achieved record gross profit margins of over 25%, an increase of 120 basis points from the previous year [5] - **Earnings Per Share**: Record earnings per share driven by the Texture and Healthful Solutions segment, returning $435 million to shareholders through dividends and share repurchases [5] - **Cash Generation**: Averaged $1 billion in cash generation over the last three years, providing a strong balance sheet and financial flexibility [5] Strategic Vision and Growth Opportunities - **Resegmentation**: The company resegmented its business into three large global segments to enhance customer intimacy and innovation delivery [6] - **Texture and Healthful Solutions**: Positioned to capitalize on macro trends such as natural high-intensity sweeteners and protein fortification, with a focus on clean label products [9][10] - **Consumer Trends**: Increasing consumer preference for clean labels, high protein, and high fiber products, with the clean label category growing at a compounded annual growth rate (CAGR) of 6% over the last four years [10][11] Market Position and Competitive Advantages - **Global Leadership**: Ingredion is a leader in texture solutions, with a strong presence in North America, Europe, and APAC [18] - **Consumer Insights**: 85% of consumers are likely to recommend food based on texture, indicating a significant opportunity for growth in this area [19] - **Private Label Growth**: The company is well-positioned to benefit from the increasing shift towards private label products, with private label growth in EMEA at over 40% [36][37] Regional Performance - **LatAm Segment**: Generated approximately $2.5 billion in revenue with a segment operating income margin of 21%. Strong local presence with nine plants and three innovation centers [40][42] - **U.S. and Canada Segment**: Achieved $2 billion in net sales with a 16% operating income margin. The company is the only corn wet miller with assets in Canada, optimizing supply chain efficiency [41][46] Innovation and R&D - **Idea Labs**: 30 Idea Labs globally to customize solutions based on local tastes and preferences [4][18] - **Solutions Business**: Approximately $1 billion in sales, growing at 7.5%, with a focus on customer intimacy and co-creation of products [25][26] Future Outlook - **Revenue Growth**: Projected net sales growth of 1% to 3% through 2028, with mid-single digits operating income growth expected [54][55] - **Investment in CapEx**: About $200 million in capital expenditures to enhance production capabilities and support growth initiatives [38] - **Enterprise Productivity**: A multi-year program aimed at improving efficiency and effectiveness, expected to contribute over 1 point of operating income growth by 2028 [58] Risks and Challenges - **Market Volatility**: Ongoing tariff and trade risks, regulatory impacts, and economic growth uncertainties [56][57] - **Consumer Behavior Changes**: Shifts in consumer preferences and economic conditions affecting demand for certain product categories [54] Conclusion - Ingredion is strategically positioned for growth through innovation, customer intimacy, and a strong market presence in key regions. The company is focused on leveraging macro trends in health and wellness, clean labels, and private label growth to drive future performance.

巴克莱银行在2026年02月04日发布报告，维持宜瑞安(INGR.N)的"持有"评级，并将目标价从124美元上 调至128美元。该调整反映了机构对公司在食品配料领域的稳健表现预期。 股票近期走势 经济观察网巴克莱银行发布报告，维持宜瑞安(INGR.N)的"持有"评级，并将目标价从124美元上调至128 美元。该调整反映了机构对公司在食品配料领域的稳健表现预期。 机构观点 近7天(2026年02月06日至02月11日)，宜瑞安股价区间涨跌幅为0.77%，振幅达3.86%。股价在02月06日 最高触及121.75美元，02月11日收盘报119.80美元，当日涨幅0.91%。同期成交额约3.02亿美元，换手率 显示交易活跃度一般。 以上内容基于公开资料整理，不构成投资建议。 ...

Financial Data and Key Metrics Changes - For Q4 2025, net sales were $1.8 billion, down 2% year-over-year, with gross profit dollars decreasing by 4% and gross margin slightly lower at 24.5% [17][20] - Full year 2025 net sales were $7.2 billion, down 3% compared to the previous year, while gross profit dollars increased by 2% and gross margin improved to 25.3% [20] - Adjusted operating income for Q4 was $228 million, while full year adjusted operating income was $1.028 billion [17][20] Business Line Data and Key Metrics Changes - Texture and Healthful Solutions segment saw net sales up 1% for the full year, driven by 4% sales volume growth, while operating income increased by 16% [22] - Food and Industrial Ingredients LATAM reported a 4% decrease in net sales for the full year, but operating income increased to $493 million, achieving a record operating income margin of 21.1% [22] - Food and Industrial Ingredients U.S./Canada net sales declined by 7% for the full year, with operating income down 16% due to production challenges at the Argo facility [23] Market Data and Key Metrics Changes - In LATAM, brewing adjunct volume demand began to recover, but challenges remained in the confectionery and paper sectors, leading to overall volume declines [7] - In the U.S./Canada, beverage sweetener volumes faced softness, contributing to lower sales in the Food and Industrial Ingredients segment [10] Company Strategy and Development Direction - The company is focusing on clean label ingredients and solutions, which are among the fastest-growing areas in the food industry, supported by proprietary technology and consumer insights [6] - Strategic capital growth and cost savings investments were completed, including a starch modernization project and the expansion of a blending center, expected to drive revenue potential [8] - The company aims to enhance operational excellence and productivity, with a target of $400-$440 million in capital expenditures for 2026 [78] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in recovering from operational challenges at the Argo facility, with expectations for gradual improvement throughout 2026 [10][32] - The company anticipates low single-digit to mid-single-digit growth in net sales for 2026, reflecting greater volume demand, despite facing manufacturing inflation [25][29] - Management highlighted the importance of maintaining flexibility for strategic M&A opportunities while committing to a minimum of $100 million in share repurchases for 2026 [75][76] Other Important Information - The company reported a full year cash from operations of $944 million and returned $435 million to shareholders through dividends and share repurchases [24][32] - The CFO announced retirement effective March 31, 2026, with a search for a successor already underway [16] Q&A Session Summary Question: Impact of Argo facility on volume decline - Management indicated that the Argo facility's operational challenges had a $16 million impact in Q4 and a total of $40 million for 2025, with expectations for recovery in 2026 [36][39] Question: Texture and Healthful Solutions pricing and ASP - Management noted that pricing for Texture and Healthful Solutions was slightly down, with expectations for volume gains year-over-year, but not fully covering manufacturing cost inflation [71][72] Question: LATAM business volume movements - Management clarified that Q4 sales volume in LATAM declined by 3%, primarily due to brewing adjunct volume declines, while food and beverage volumes showed positive growth [55] Question: Breakdown of food versus beverage sales in Mexico - Management estimated that brewing adjunct and beverages account for about 40% of sales, with food and industrial products making up the remainder [89][90] Question: Expected recovery from Argo facility in 2026 - Management projected that approximately $20 million of the $40 million impact from Argo could be recovered in the second half of 2026 [94]

Financial Data and Key Metrics Changes - For Q4 2025, net sales were $1.8 billion, down 2% year-over-year, with gross profit dollars decreasing by 4% and gross margin slightly lower at 24.5% [18] - Full year 2025 net sales were $7.2 billion, down 3% compared to the previous year, while gross profit dollars increased by 2% and gross margin improved to 25.3% [21] - Adjusted operating income for Q4 was $228 million, while full year adjusted operating income was $1.028 billion [18][21] Business Line Data and Key Metrics Changes - Texture and Healthful Solutions segment saw net sales up 1% for the full year, driven by 4% sales volume growth, while operating income increased by 16% [23] - Food and Industrial Ingredients LATAM reported a 4% decline in net sales, primarily due to weaker volumes in brewing adjuncts, but operating income increased to $493 million with a margin of 21.1% [24] - Food and Industrial Ingredients US/Canada experienced a 7% decline in net sales, with a 4% decrease in sales volume attributed to operational challenges at the Argo facility [24] Market Data and Key Metrics Changes - Clean label ingredient volumes grew significantly in Q4 and throughout the year, particularly in Asia-Pacific and US/Canada, highlighting its importance in the food industry [6][7] - In LATAM, food ingredient sales experienced modest growth, while brewing adjunct demand was recovering from long-term contracted customers [8] Company Strategy and Development Direction - The company is focusing on solutions and clean label offerings, which have significantly enhanced results in the Texture and Healthful segment [12] - Strategic capital growth and cost savings investments were completed, including a starch modernization project and the expansion of a blending center [9] - The company aims to drive profitable growth through innovation and operational excellence, with a focus on higher-margin products and customer engagement [15][32] Management's Comments on Operating Environment and Future Outlook - Management acknowledged unforeseen challenges in 2025 but highlighted record operating income and margins, emphasizing the resilience of the LATAM business [10][16] - For 2026, the company anticipates low single-digit growth in net sales and operating income, with expectations of continued volume demand and challenges from manufacturing inflation [26][30] Other Important Information - The company repurchased $224 million of outstanding common shares and paid out $211 million in dividends, marking the 11th consecutive annual dividend increase [25] - A transition in CFO is underway, with Jim Gray set to retire in March 2026, and a search for his successor has begun [17] Q&A Session Summary Question: Impact of Argo facility on volume decline - Management indicated that the Argo facility's operational challenges had a $16 million impact in Q4 and a total of $40 million for 2025, with expectations of recovery in 2026 [35][37][39] Question: Texture and Healthful Solutions pricing and ASP - Management noted that pricing for Texture and Healthful Solutions was slightly down, with expectations for volume gains year-over-year, but not fully covering manufacturing cost inflation [72][73] Question: LATAM business volume movements - Management clarified that Q4 sales volume in LATAM declined by 3%, primarily due to brewing adjuncts, while food and beverage volumes showed positive growth [58] Question: Breakdown of food versus beverage sales in Mexico - Management estimated that brewing adjunct and beverages account for about 40% of sales, with food and industrial products making up the remainder [90] Question: Expected recovery from Argo facility in 2026 - Management anticipates recovering about $20 million of the Argo impact in the second half of 2026, with ongoing challenges expected in Q1 [97]

Core Viewpoint - Tianjiao Biotechnology Co., Ltd. has completed its IPO counseling registration and is preparing for its listing on the New Third Board, with a structured four-phase approach to ensure compliance and governance [2][4]. Group 1: Company Overview - Tianjiao Biotechnology was established in December 2004, with a registered capital of 51.03 million yuan, located in Heze City, specializing in the research, production, and sales of food ingredients [4]. - The company has received multiple accolades, including being recognized as a national high-tech enterprise and a leading enterprise in Shandong Province's "Top Ten" industrial clusters [4]. - The controlling shareholder is Shandong Tianjiu Industrial Group Co., Ltd., which holds 82.39% of the shares, with the actual controllers indirectly controlling 84.35% of the company [4]. Group 2: Business Operations - Tianjiao Biotechnology focuses on functional powdered oils, solid beverages, and baking materials, with a strong emphasis on R&D [4]. - The company has established a multi-dimensional R&D framework, including six provincial-level R&D platforms and four major R&D centers across China, holding 77 patents, including 22 invention patents [4]. Group 3: Financial Aspects - The company faces risks related to raw material price fluctuations, with direct material costs constituting 84.81%, 83.50%, and 83.81% of the main business costs for 2023, 2024, and the first half of 2025, respectively [5]. - Due to rising product costs, the gross profit margin for the main business decreased to 22.46% in the first half of 2025 [5].

Financial Data and Key Metrics Changes - Adjusted EBITDA has increased each of the last five years, with a compound annual growth rate (CAGR) of 9% over that period [24] - Free cash flow has also risen year-over-year over the last five years, particularly strong on the tobacco side [24] - The company maintains a conservative debt level, around 2.5 times Adjusted EBITDA, allowing for future opportunities as debt is paid down [25] Business Line Data and Key Metrics Changes - The tobacco business continues to generate strong and consistent cash flows, with segment operating income showing growth over the last five years [11] - The new Universal Ingredients segment has been established, focusing on growth through acquisitions and organic development, with significant investments made since 2018 [16][19] - The company has invested over $30 million in expanding capabilities within the ingredients segment, enhancing extraction and packaging processes [18] Market Data and Key Metrics Changes - The company operates in over 30 countries across five continents, maintaining a strong global footprint in strategic markets [2] - The competitive landscape includes global leaf suppliers, vertically integrated customers, and local suppliers, with the company positioned to capture additional market share [10][11] Company Strategy and Development Direction - The corporate strategy is built on three pillars: maximizing the tobacco business, growing the ingredients business, and strengthening the company for future sustainability [5] - The company aims to leverage its strengths in agronomy, processing, and logistics to maintain its leading market position and enhance operational efficiency [12][15] - Sustainability is a core focus, with initiatives aimed at supporting farmers and meeting customer expectations in both tobacco and ingredients segments [22][23] Management's Comments on Operating Environment and Future Outlook - The management expresses confidence in the company's ability to grow both the tobacco and ingredients businesses, emphasizing the importance of sustainability in future market trends [24][27] - The company is focused on building a solid foundation for the next 100 years, with a commitment to improving financial performance and shareholder returns [26][28] Other Important Information - The company has achieved its 55th consecutive annual increase in dividends, reflecting its commitment to returning value to shareholders [25] - Sustainability reports are regularly published, showcasing the company's progress and goals in this area [23] Q&A Session Summary Question: What is the outlook for the ingredients segment? - The company is looking to scale up the ingredients segment to generate volume and margin, focusing on co-creating products with customers to meet market trends [19][20] Question: How does the company plan to maintain its competitive advantage in the tobacco market? - The company emphasizes its strong sourcing capabilities, processing efficiency, and logistics expertise as key factors in maintaining its market leadership [12][15]

Financial Data and Key Metrics Changes - Adjusted EBITDA has increased each of the last five years, with a compound annual growth rate (CAGR) of 9% over that period [24] - Free cash flow has also risen year over year during the last five years, particularly strong on the tobacco side [24] - The company maintains a debt level around 2.5 times Adjusted EBITDA, focusing on fiscal conservatism and maintaining credit ratings [25] Business Line Data and Key Metrics Changes - The tobacco business continues to generate strong and consistent cash flows, with segment operating income showing growth over the last five years [11] - The new Universal Ingredients segment has been established, focusing on growth through acquisitions and organic development, with significant investments made since 2018 [16][19] - The company has invested over $30 million in expanding capabilities within the ingredients segment, enhancing extraction and packaging processes [18] Market Data and Key Metrics Changes - The company operates in over 30 countries across five continents, maintaining a strong global footprint in strategic markets [2] - The competitive landscape includes global leaf suppliers, vertically integrated customers, and local suppliers, with the company positioned to capture additional market share [10][11] Company Strategy and Development Direction - The corporate strategy is built on three pillars: maximizing the tobacco business, growing the ingredients business, and strengthening the company for future sustainability [5] - The company aims to leverage its strengths in sustainability, particularly in the tobacco sector, to gain a competitive advantage in the ingredients market [22][24] - There is a focus on co-creating value-added products with customers to meet evolving market trends and demands [20] Management's Comments on Operating Environment and Future Outlook - The management expresses confidence in the company's ability to grow both the tobacco and ingredients segments, emphasizing the importance of sustainability and operational efficiency [26][27] - The management highlights the excitement surrounding the company's future, particularly in scaling the ingredients business and maintaining strong performance in tobacco [27][28] Other Important Information - The company has a long history of increasing dividends, marking its 55th consecutive annual increase, reflecting strong cash generation and commitment to shareholder returns [25] - Sustainability efforts are a key focus, with the company actively collecting data and reporting on its sustainability initiatives [22][23] Q&A Session Summary - No specific questions or answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - Adjusted EBITDA has increased each of the last five years, with a compound annual growth rate (CAGR) of 9% over that period [26] - Free cash flow has also risen year over year for the last five years, particularly strong on the tobacco side [26] - The company maintains a conservative debt level, around 2.5 times Adjusted EBITDA, allowing for future opportunities as debt is paid down [27] Business Line Data and Key Metrics Changes - The tobacco business continues to generate strong and consistent cash flows, with segment operating income showing growth over the last five years [12] - The new Universal Ingredients segment has been established, focusing on growth through acquisitions and organic development, with significant investments made since 2018 [17][20] - The company has invested over $30 million in expanding capabilities within the ingredients segment, enhancing extraction and packaging processes [19] Market Data and Key Metrics Changes - The company operates in over 30 countries across five continents, maintaining a strong global footprint in strategic markets [2] - Universal is the world's leading leaf tobacco supplier, with a competitive advantage over both global leaf suppliers and vertically integrated customers [10][11] - Sustainability is becoming increasingly important in both the tobacco and ingredients markets, with the company leveraging its expertise to gain a competitive edge [25][26] Company Strategy and Development Direction - The corporate strategy is built on three pillars: maximizing the tobacco business, growing the ingredients business, and strengthening the company for the next 100 years [5] - The company aims to increase volume and market share in the tobacco sector while optimizing operational efficiency [5][6] - For the ingredients segment, the focus is on organic growth and strategic acquisitions to enhance product offerings and market reach [20] Management's Comments on Operating Environment and Future Outlook - Management expresses confidence in the company's strong performance and strategic direction, emphasizing the importance of sustainability and innovation [24][28] - The company is focused on building a solid foundation for future growth, particularly in the ingredients segment, which is seen as a significant opportunity [29] - There is an expectation that sustainability will become increasingly critical in the food and beverage markets, aligning with consumer trends [25] Other Important Information - The company has a long history of dividend increases, marking its 55th consecutive annual increase, reflecting strong financial health and commitment to shareholders [27] - Sustainability reports are regularly published, showcasing the company's progress and commitment to environmental stewardship [24][25] Q&A Session Summary Question: What is the outlook for the ingredients segment? - The company is looking to scale up the ingredients business to generate volume and income, leveraging its diverse product portfolio to meet changing market trends [20] Question: How does the company plan to maintain its competitive advantage in tobacco? - The company focuses on sourcing, processing, and logistics, ensuring strong relationships with farmers and customers while maintaining operational efficiency [13][16] Question: What role does sustainability play in the company's strategy? - Sustainability is a core focus, with the company implementing strict programs for farmers and aiming to leverage its expertise in both tobacco and ingredients markets [24][25]

Group 1: Food Safety Concerns - The excessive use of additives, such as water-retaining agents in shrimp products, has raised significant safety concerns, with one company exceeding the legal limit of phosphate by 145% [2] - Microbial contamination, particularly from botulinum toxin, remains a major risk in food safety, necessitating strict control measures from production to storage [3] - Experts emphasize that the safety of long shelf-life foods does not correlate directly with their nutritional value, and modern processing techniques can ensure both safety and nutrition [3] Group 2: Industry Trends and Innovations - The demand for "suitable elderly food" is increasing, with a significant gap in the market for scientifically defined products that cater to the nutritional needs of older adults [5] - The approval of D-alloheptulose as a new food ingredient marks a significant advancement in synthetic biology applications within the food industry, indicating a mature technological and policy framework [5] - The introduction of new food safety standards, including updated labeling regulations, aims to enhance consumer awareness and safety, addressing long-standing industry concerns [6][7] Group 3: Regulatory Developments - The release of 50 new national food safety standards, including those for prepackaged food labeling, represents a significant upgrade in food labeling management [6] - The new regulations require clear labeling of expiration dates and allergenic substances, aiming to reduce food allergy risks and improve consumer information [6] - The implementation of comprehensive food safety regulations across the entire supply chain reflects a shift towards proactive risk management and consumer safety [7]

Core Viewpoint - The company emphasizes the importance of strategic determination and business synergy for high-quality development in a complex global economic environment, with a focus on diversified layout and stable operations [1] Financial Performance - For the six months ending June 30, 2025, the company reported total revenue of approximately 1.621 billion yuan, representing a year-on-year increase of 2.5% [1] - The profit attributable to equity holders reached approximately 118 million yuan, showing a significant year-on-year growth of 298.1%, indicating strong operational resilience [1] Business Segments - The flavor and food ingredients segment, as a core area, has strengthened its technical capabilities in microwave drying and extraction, effectively meeting the demand for natural extracts from Chinese tea beverage brands [3] - In the tobacco raw materials segment, the new reconstituted tobacco leaf production line at the Indonesian production base has achieved bulk supply, with steadily increasing capacity utilization, serving as a key driver for sustainable development [3] - The tobacco capsule business is actively expanding into overseas markets, achieving rapid revenue growth through the development of region-specific flavors and technological upgrades [3] - The flavor raw materials segment has maintained stable revenue amidst fluctuations in overseas market demand through cost control and new customer development [3] - The seasoning business focuses on value innovation in the catering channel, enhancing customer engagement through online live broadcasts and offline promotional activities, with the number of primary distributors reaching 956 [3] Innovation and Risk Management - The company's philosophy of balancing technological innovation and risk management is reflected in its mid-term performance, with R&D investment of approximately 125 million yuan, accounting for 7.7% of revenue, and multiple technological achievements reaching industry-leading levels [4] - The company has optimized processes and improved systems across various dimensions, including climate change, safety production, and compliance, while integrating AI technology into operational management to enhance intelligence and digitalization, effectively reducing operational risks [4] - Cash generated from operating activities reached 214 million yuan, a year-on-year increase of 88.6%, with a maintained low debt-to-asset ratio, indicating a robust financial structure that provides ample funding for future development [4] Future Outlook - The company plans to continue deepening multi-business collaborative development under the strategic guidance of its CEO, focusing on the health sector and overseas market expansion, while enhancing core competitiveness through technological innovation and refined management to create greater value for shareholders [4]